Related references
Note: Only part of the references are listed.Evaluation of antidiabetic and antioxidant potential of lupeol in experimental hyperglycaemia
Rajnish Gupta et al.
NATURAL PRODUCT RESEARCH (2012)
Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice
Xiaoyan Sheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism
Yaoyao Jia et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Protective effect of Ilex latifolia, a major component of kudingcha, against transient focal ischemia-induced neuronal damage in rats
Joo Youn Kim et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Ursolic Acid, a Pentacyclic Triterpene from Sambucus australis, Prevents Abdominal Adiposity in Mice Fed a High-Fat Diet
Vietla S. Rao et al.
JOURNAL OF MEDICINAL FOOD (2011)
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants
Mariel M. Finucane et al.
LANCET (2011)
Protective Effects of White Button Mushroom (Agaricus bisporus) against Hepatic Steatosis in Ovariectomized Mice as a Model of Postmenopausal Women
Noriko Kanaya et al.
PLOS ONE (2011)
Genetic Link Between Obesity and MMP14-Dependent Adipogenic Collagen Turnover
Tae-Hwa Chun et al.
DIABETES (2010)
Ursolic Acid and Luteolin-7-Glucoside Improve Lipid Profiles and Increase Liver Glycogen Content through Glycogen Synthase Kinase-3
Marisa F. Azevedo et al.
PHYTOTHERAPY RESEARCH (2010)
Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARα, PPARγ and LXRα
Jonathan Goldwasser et al.
PLOS ONE (2010)
Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta
Junghyun Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity
K. Papi Reddy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
The Role of Tanshinone IIA in the Treatment of Obesity through Peroxisome Proliferator-Activated Receptor gamma Antagonism
Zhenwei Gong et al.
ENDOCRINOLOGY (2009)
Comparison of Major Phenolic Constituents and in Vitro Antioxidant Activity of Diverse Kudingcha Genotypes from Ilex kudingcha, Ilex cornuta, and Ligustrum robustum
Fan Zhu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia
Adelheid Kratzer et al.
JOURNAL OF LIPID RESEARCH (2009)
Inhibitory Effect of Triterpenoid Saponins from the Leaves of Ilex kudingcha on Aggregated LDL-Induced Lipid Deposition in Macrophages
Jiao Zheng et al.
PLANTA MEDICA (2009)
Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect
Sung I. Koo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2007)
The nuclear receptor LXR is a glucose sensor
Nico Mitro et al.
NATURE (2007)
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Cheng Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Green tea catechins inhibit pancreatic phospholipase A2 and intestinal absorption of lipids in ovariectomized rats
Shu Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2006)
Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage
I Raz et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR
G Chinetti et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Obesity wars: Molecular progress confronts an expanding epidemic
JS Flier
CELL (2004)
LXR-dependent gene expression is important for macrophage survival and the innate immune response
SB Joseph et al.
CELL (2004)
Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis
EG Lund et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
BA Laffitte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
LXRs; Oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis
PA Edwards et al.
VASCULAR PHARMACOLOGY (2002)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
Antioxidative activities of phenylethanoid glycosides from Ligustrum purpurascens
IYF Wong et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis
C Song et al.
STEROIDS (2001)
The nuclear receptors FXR and LXRα:: Potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases
EJ Niesor et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
S Alberti et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
